siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells.
The creation of complex tissues and organs is the ultimate goal in tissue engineering. Engineered morphogenesis necessitates spatially controlled development of multiple cell types within a scaffold implant. We present a novel method to achieve this by adhering nanoparticles containing different small-interfering RNAs (siRNAs) into nanostructured scaffolds. This allows spatial retention of the RNAs within nanopores until their cellular delivery. The released siRNAs were capable of gene silencing BCL2L2 and TRIB2, in mesenchymal stem cells (MSCs), enhancing osteogenic and adipogenic differentiation, respectively. This approach for enhancing a single type of differentiation is immediately applicable to all areas of tissue engineering. Different nanoparticles localized to spatially distinct locations within a single implant allowed two different tissue types to develop in controllable areas of an implant. As a consequence of this, we predict that complex tissues and organs can be engineered by the in situ development of multiple cell types guided by spatially restricted nanoparticles.
Andersen
Morten Ø
MØ
Interdisciplinary Nanoscience Center, Aarhus University, Aarhus C, Denmark.
Nygaard
Jens V
JV
Burns
Jorge S
JS
Raarup
Merete K
MK
Nyengaard
Jens R
JR
Bünger
Cody
C
Besenbacher
Flemming
F
Howard
Kenneth A
KA
Kassem
Moustapha
M
Kjems
Jørgen
J
D017667:Adipocytes / Q000166:cytology* / Q000378:metabolism; D000818:Animals; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D015153:Blotting, Western; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D002454:Cell Differentiation / Q000235:genetics*; D049109:Cell Proliferation; D002478:Cells, Cultured; D020219:Chondrogenesis; D051747:DNA-Activated Protein Kinase / Q000502:physiology; D004268:DNA-Binding Proteins / Q000502:physiology; D005260:Female; D005434:Flow Cytometry; D020868:Gene Silencing; D049452:Green Fluorescent Proteins / Q000235:genetics; D006801:Humans; D007124:Immunoenzyme Techniques; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000378:metabolism; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D053758:Nanoparticles / Q000648:ultrastructure; D049329:Nanostructures / Q000737:chemistry* / Q000648:ultrastructure; D009687:Nuclear Proteins / Q000502:physiology; D010006:Osteoblasts / Q000166:cytology* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D023822:Tissue Engineering; D054457:Tissue Scaffolds
D051017:Apoptosis Regulatory Proteins; C491073:BCL2L2 protein, human; D004268:DNA-Binding Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009687:Nuclear Proteins; D012333:RNA, Messenger; D034741:RNA, Small Interfering; C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; D051747:DNA-Activated Protein Kinase; C497264:Prkdc protein, mouse; D017871:Calcium-Calmodulin-Dependent Protein Kinases; C489044:TRIB2 protein, human
Biochem Biophys Res Commun. 2007 Jun 15;357(4):997-1003
17459335
Pharm Res. 2009 Mar;26(3):512-22
19023647
Science. 1999 Dec 17;286(5448):2244-5
10636774
J Am Chem Soc. 2009 Jul 8;131(26):9204-6
19530653
Am J Physiol Endocrinol Metab. 2006 May;290(5):E916-24
16368784
Lancet. 2008 Dec 13;372(9655):2023-30
19022496
Int J Pharm. 1999 Jun 10;183(1):25-8
10361148
Methods Mol Biol. 2008;455:89-100
18463812
Exp Cell Res. 2008 Jul 1;314(11-12):2257-65
18570921
Nat Biotechnol. 1999 Jun;17(6):551-4
10385318
Dev Biol. 2009 Feb 15;326(2):431-43
19073166
Wound Repair Regen. 2007 May-Jun;15(3):286-95
17537114
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9673-8
17535907
Mol Ther. 2005 Sep;12(3):475-83
15950542
Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1226-31
18212116
Dev Biol. 2009 Aug 1;332(1):116-30
19464283
J Tissue Eng Regen Med. 2007 May-Jun;1(3):170-8
18038408
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12170-5
18719120
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2889-94
18287052
J Biol Chem. 2005 Jul 15;280(28):26630-9
15905178
Nat Biotechnol. 2002 Jun;20(6):592-6
12042863
Plast Reconstr Surg. 2009 Feb;123(2 Suppl):149S-157S
19182674
Hepatol Res. 2007 Dec;37(12):1068-79
17627621
Yonsei Med J. 2000 Dec;41(6):704-19
11204822
Cell. 2004 Apr 2;117(1):1-3
15066275
Biomaterials. 2004 May;25(11):2095-103
14741624
Regen Med. 2008 Jan;3(1):93-103
18154465
Bone. 1995 Aug;17(2 Suppl):77S-83S
8579903
Biomaterials. 2009 Mar;30(8):1587-95
19108884
BMC Mol Biol. 2008 Oct 31;9:98
18976469
Gene Ther. 2005 Mar;12(5):418-26
15647766
PLoS One. 2009;4(5):e5605
19440384
J Biomed Mater Res. 1999 Oct;47(1):8-17
10400875
Biomaterials. 2008 Feb;29(4):506-12
17950838
J Biol Chem. 2007 Aug 17;282(33):24075-82
17576771
Science. 1993 May 14;260(5110):920-6
8493529
J Lipid Res. 2008 Apr;49(4):880-92
18187772
Gene Ther. 2008 Jan;15(2):109-16
17989700
RNA. 2007 Aug;13(8):1179-83
17556710
Hum Gene Ther. 2006 Mar;17(3):253-63
16544975
Biochem Biophys Res Commun. 2005 May 13;330(3):633-40
15809044
Mol Cell Biochem. 2007 Dec;306(1-2):123-32
17657589
Lancet. 2006 Apr 15;367(9518):1241-6
16631879
Mol Cell Biol. 2007 Oct;27(19):6818-31
17646392
Pharm Res. 2009 Feb;26(2):263-75
19015958
Tissue Eng Part A. 2008 Jan;14(1):127-33
18333811